Health Care & Life Sciences » Pharmaceuticals | Kwang Dong Pharmaceutical Co. Ltd.

Kwang Dong Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Kwang Dong Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fidelity Low Priced Stock Fund
3,100,000
5.91%
0
0.06%
04/30/2018
Fidelity Series Intrinsic Opportunities Fund
2,400,000
4.58%
0
0.13%
04/30/2018
Government Pension Fund - Global (The)
821,102
1.57%
127,016
0%
12/31/2017
iShares Core MSCI Emerging Markets ETF
620,773
1.18%
0
0.01%
09/05/2018
Vanguard Total International Stock Index Fund
403,996
0.77%
0
0%
07/31/2018
DFA Emerging Markets Core Equity Portfolio
335,820
0.64%
29,933
0.01%
04/30/2018
DFA Emerging Markets Small Cap Series
313,294
0.6%
0
0.03%
01/31/2018
219,000
0.42%
0
0.16%
03/31/2018
CREF Stock Account
197,213
0.38%
0
0%
03/31/2018
Vanguard Developed Markets Index Fund
168,119
0.32%
0
0%
07/31/2018

About Kwang Dong Pharmaceutical Co.

View Profile
Address
85 Seochojungang-ro
Seoul SL 06650
Korea, Republic Of
Employees -
Website http://www.ekdp.com
Updated 07/08/2019
Kwang Dong Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Pharmacy Sales, Hospital Sales, Distribution Sales, Water Sales and Others. The Pharmacy Sales division provides medicines for cold, high blood pressure and cerebral apoplexy.